Finalists Announced for OBN Awards 2016

OBN Ltd, the membership organisation supporting the UK’s innovative life sciences companies has announced the finalists of its 8th Annual Awards covering Biotech, Medtech, Synthetic Biology and Digital Health.

The OBN Awards remain proudly independent, celebrating innovation and achievement across the UK life sciences industry and recognising achievements from emerging to late stage R&D companies as well as life sciences investors.

A judging panel comprising a range of industry experts has been assembled to decide the overall winner in each category, with the winning companies being announced at the OBN Awards Ceremony on Thursday 6th October at the Oxford Town Hall.

We are delighted that Vaccitech Limited feature as a finalist for Best Start-up Biotech Company:

Best Start-up Biotech Company Award
Kindly sponsored by Penningtons Manches

Elasmogen
Freeline Therapeutics
OxStem
Vaccitech

For those of you wishing to attend the event – individual tickets for the awards on Thursday 6th October are still available, to book please visit obn-awards.com